Cardinal Health Overview
Valuation check: CAH's ROE is -59.45%, below the Industrials sector average of 8.49%.
Get informed when a big investor buys or sells
+ Follow-59.45%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Cardinal Health (CAH) currently reports a ROE of -59.45%. That is below the Industrials sector average of 8.49%. Use the charts on this page to explore Cardinal Health's ROE history and peer comparisons.
Cardinal Health's ROE of -59.45% is lower than the Industrials sector average of 8.49%. That is roughly 800.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Cardinal Health's current -59.45% should be judged against Industrials norms (sector average: 8.49%) and against CAH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -59.45%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 8.49%. From there, open related valuation or income-statement pages for Cardinal Health, and consider following CAH for alerts when major investors trade the stock.
Cardinal Health is classified in the Industrials sector. On ROE, it currently shows -59.45% versus a sector average near 8.49%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing CAH with unrelated industries.
